Hyperbaric Oxygen Therapy in HAMstring Injury (HOTHAM) Trial
NCT06526728 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-11-20
Summary
The goal of this study is to learn if Hyperbaric Oxygen Therapy is able to accelerate and improve muscle healing following an acute hamstring injury. The main questions it aims to answer are:
1. Does Hyperbaric Oxygen Therapy accelerates the time needed to return to play/-duty following hamstring injury.
2. Does Hyperbaric Oxygen Therapy decrease the amount of reinjuries within 1 year following Return to play/-duty? Besides these questions this study will clinically and radiologically evaluate the healing process over time as well as the occurrence of (serious) adverse events.
Conditions
- Hamstring Injury
Interventions
- DRUG
-
Hyperbaric oxygen
Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy. Each session will last 115-120 minutes whereby the chambre will be pressurized to 2.4 ATA during which participants will breathe 100% (pure) oxygen.
Sponsors & Collaborators
-
JL Tol
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-30
- Primary Completion
- 2027-09-01
- Completion
- 2028-03-01
Countries
- Netherlands
Study Locations
More Related Trials
-
The Role of Nasal Breathing for Perfomance in Elite Athletes.
NCT06480071 ·Status: COMPLETED ·Phase: NA
-
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
NCT05612074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Stimulant Medications Infusion Through Midline Catheters Based on Real-world Data
NCT06454552 ·Status: NOT_YET_RECRUITING
-
Histamines and Central Hemodynamics
NCT07285031 ·Status: RECRUITING ·Phase: NA
-
Development of a Mass-spectometry Based Method for Detecting Xenon Application in Humans
NCT02105077 ·Status: COMPLETED
-
Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity
NCT04612270 ·Status: COMPLETED ·Phase: NA
-
Creatine Monohydrate Use for Preventing Altitude Induced Depression
NCT03433651 ·Status: WITHDRAWN ·Phase: PHASE4
-
Histamine H1/H2 Receptors and Training Adaptations
NCT04450134 ·Status: COMPLETED ·Phase: NA
-
Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device
NCT01356212 ·Status: COMPLETED ·Phase: PHASE1
-
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
NCT04402658 ·Status: WITHDRAWN ·Phase: NA
-
Histamine as a Molecular Transducer of Adaptation to Exercise
NCT05206227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Nitrate Supplementation on Motor Unit Activity
NCT05993715 ·Status: COMPLETED ·Phase: NA
-
Effects of Red Bull® on the Effects of Training and Haemodynamic Parameters
NCT04963556 ·Status: COMPLETED ·Phase: NA
-
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient
NCT00497978 ·Status: COMPLETED ·Phase: NA
-
The Effect of High Dose Salbutamol on Muscle Performance
NCT01415596 ·Status: UNKNOWN ·Phase: NA
-
Influence on Erythropoetin-level by Xenon
NCT02129400 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension
NCT01566565 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Histamine in Muscle Protein Synthesis Following Resistance Training
NCT06152497 ·Status: RECRUITING ·Phase: NA
-
Acute Nitrate Supplementation in Cyclists
NCT01384968 ·Status: COMPLETED ·Phase: NA
-
cAMP Signaling and Muscle Adaptations
NCT02557581 ·Status: UNKNOWN ·Phase: NA
-
Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness
NCT00745771 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia
NCT01905696 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
¹³C-Methacetin Breath Test (MBT) Methodology Study
NCT01205074 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Modulation of Metabolic Rate by Inorganic Nitrate
NCT02022176 ·Status: COMPLETED ·Phase: NA